Stockholders’ Equity (Deficit) (Tables)

9 Months Ended

Sep. 30, 2020

Stockholders' Equity Note [Abstract]

Schedule of stock option granted was estimated using the Black-Scholes assumption

Exercise price	$ 4.00-11.00
Expected dividend yield	0	%
Risk free interest rate	0.39%-2.65	%
Expected life in years	2.54-7.27
Expected volatility	141-146	%

Schedule of analysis of the stock option grant activity under the plan

			Weighted Average		Weighted Average
Stock Options	Number		Exercise Price		Remaining Life
Outstanding December 31, 2019		1,102,500	$	4.00		7.77
Granted		7,500		11.00		4.47
Expired or forfeited		-		-		-
Outstanding September 30, 2020 (unaudited)		1,110,000	$	4.05		7.00

	Number			Weighted Average Exercise Price		Weighted Average Remaining Life
Warrants
Outstanding December 31, 2019		1,382,478			4.44		2.84
Granted		8,786,381			6.30		5.00
Expired or forfeited		(190,810	)		8.12		-
Exercised		(3,740,753	)		7.53		-
Outstanding September 30, 2020 (unaudited)		6,237,296		$	5.10		4.30

Schedule of nonvested option

Nonvested Options	Shares			Weighted- Average Exercise Price
Nonvested at December 31, 2019		-		$	-
Granted		7,500			11.00
Vested		(7,500	)		11.00
Expired or forfeited		-			-
Nonvested at September 30, 2020 (unaudited)		-		$	-

Nonvested Warrants	Shares			Weighted- Average Exercise Price
Nonvested at December 31, 2019		200,000			4.00
Granted		65,000			6.30
Vested		-			-
Expired or forfeited		(65,000	)		4.00
Nonvested at September 30, 2020 (unaudited)		200,000		$	4.30